首页> 外国专利> Novel pyridylethanol (phenylethyl) amine derivatives as inhibitors of cholesterol biosynthesis, methods for their preparation and pharmaceutical compositions containing the novel derivatives

Novel pyridylethanol (phenylethyl) amine derivatives as inhibitors of cholesterol biosynthesis, methods for their preparation and pharmaceutical compositions containing the novel derivatives

机译:作为胆固醇生物合成抑制剂的新型吡啶乙醇(苯乙基)胺衍生物,其制备方法和含有该新型衍生物的药物组合物

摘要

The novel derivatives of pyridilethanol (phenylethyl) amines of formula I are described wherein n is an integer from 1 to 4, R1 is a hydrogen atom, hydroxyl group or lower C1-6alkoxy group R2 is a hydrogen atom or a straight or branched lower C1-6alkyl group X, is hydrogen, fluorine, chlorine, bromine, hydroxyl group, trifluoromethyl group, 3,4-di-Cl,2,4-di-Cl or lower C1-6alkoxy group, the enantiomers, diastereoisomers or racemates thereof or the physiologically acceptable acid addition salts thereof which are ligands of sigma receptors for inhibiting cholesterol biosynthesis and are thus appropriate for the treatment of hypercholesterolemia and hyperlipemia in humans. The greatest lowering of cholesterol was observed by 1-(d-pyridyl)-2-(N-(2-(3,4-dicholorophenyl)ethyl-N-propylamino)ethanol in the form of dihydrobromide salt (signature BK-35, 2HBr).
机译:描述了式I的吡啶乙醇(苯乙基)胺的新型衍生物,其中n是1-4的整数,R1是氢原子,羟基或低级C1-6烷氧基,R2是氢原子或直链或支链低级C1 -6烷基X是氢,氟,氯,溴,羟基,三氟甲基,3,4-二-Cl,2,4-二-Cl或低级C1-6烷氧基,对映异构体,非对映异构体或外消旋体或它们的生理学上可接受的酸加成盐是sigma受体的配体,用于抑制胆固醇的生物合成,因此适用于治疗人的高胆固醇血症和高脂血症。胆固醇的最大降低是通过以二氢溴酸盐的形式(签名BK-35,1-(d-吡啶基)-2-(N-(2-(3,4-二氯苯基)乙基-N-丙基氨基)乙醇)观察到的。 2HBr)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号